This is a double-blind, placebo-controlled trial of 120 binge-drinking MSM to 12 weeks of naltrexone 50mg, to be taken in anticipation of heavy drinking. Ethnically and racially diverse participants will be recruited using Respondent Driven Sampling as well as active field recruitment. MSM will be seen weekly for alcohol-metabolite urine testing, study drug dispensing, and brief counseling for alcohol use. Safety assessments and behavioral surveys will be completed monthly.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Binge Drinking Days Per Week
Timeframe: 12 weeks
Positive Ethyl Glucuronide (EtG) Tests
Timeframe: 12 weeks
Male Anal Sex Partners
Timeframe: 12 weeks
Unprotected Anal Sex Partners While Intoxicated With Alcohol
Timeframe: 12 weeks
HIV-serodiscordant Unprotected Anal Sex Partners
Timeframe: 12 weeks
Unprotected Anal Sex Events With Serodiscordant Partners
Timeframe: 12 weeks